CRON Stock Forecast: Recovery Ahead As New Products Launched
This CRON stock forecast article was written by Maria Grishaev, Analyst at I Know First.
Executive Summary
- Cronos Group Inc. had a mixed year in 2020 with their stock losing 2.66%, mostly due to the COVID-19 pandemic.
- Quantitative analysis results indicate bullish signals after stock price topped out the moving average line.
- With the new Biden administration and the legalization of cannabis in five new states in the US, the new product launches worldwide, the company’s future is looking better.
- Based on the Multiples Valuation model, my price target for CRON is 18$, indicating a cautious buy recommendation.